Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local treatment for breast cancer liver metastases (BreCLIM-2)
NCT04079049Phase 3Recruiting
- Sponsor
- Umeå University
- Start
- Jan 2020
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in breast cancer and liver metastasis, sponsored by Umeå University. Primary endpoint: Overall Survival at 3 years. Started Jan 2020; status: recruiting.
02
Conditions
breast cancerliver metastasis
Beyond the preview
Go deeper on NCT04079049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04079049.